Onyvax Limited
7Patents
2Active
7Granted
27Portfolio score
Filing activity: Dec 9, 1999 → Jan 17, 2012 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6699483B1 | Cancer treatments | Human Necessities | 13 | Expired |
| US6972128B1 | Use of human prostrate cell lines in prostate cancer treatment | Human Necessities | 6 | Expired |
| US7438922B2 | Human prostate cell lines in cancer treatment | Human Necessities | 1 | Expired |
| US8097244B2 | Human prostate cell lines in cancer treatment | Human Necessities | 1 | Active |
| US7303911B2 | Prostate cell lines | Human Necessities | 0 | Expired |
| US8034360B2 | Use of human prostate cell lines in cancer treatment | Human Necessities | 0 | Expired |
| US8545835B2 | Human prostate cell lines in cancer treatment | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.